Why Australia?

Australia is ranked in the top tier of international clinical trial activity and is an ideal market for testing innovative therapeutics. Australia offers international partnering opportunities to conduct Phase I – IV clinical trials, as well as to develop and manufacture targets for clinical trials. Investors in Australia benefit from a:

• Strategic location with proximity to Asian markets
• Supportive government with a generous R&D tax incentive scheme
• Regulatory system that is fast and globally respected
• Streamlined customs processes and duty-free importation of clinical trial kits and placebos
• Strong intellectual property protection expertise
• Sophisticated clinical environment including more than 50 clinical trial networks, more than 50 biobanks and quality clinical data
• Research excellence through a collaborative culture and highly skilled workforce

Clinical trials in Australia

The past decade has seen a significant increase in clinical trial activity in Australia. The number of clinical trials registered annually grew by ~30 per cent between 2015 and 2019.

This reflects Australia’s capabilities in clinical research, in addition to global trends in clinical trial activity. Every year, around 1,880 new clinical trials are commenced in Australia by pharmaceutical, biotechnology and medical device companies.